Wayne Matson
Overview
Explore the profile of Wayne Matson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
417
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Steen N, Dieset I, Hope S, Vedal T, Smeland O, Matson W, et al.
Psychol Med
. 2019 Mar;
50(4):595-606.
PMID: 30867076
Background: We aimed at exploring potential pathophysiological processes across psychotic disorders, applying metabolomics in a large and well-characterized sample of patients and healthy controls. Methods: Patients with schizophrenia and bipolar...
2.
Rosas H, Doros G, Bhasin S, Thomas B, Gevorkian S, Malarick K, et al.
Ann Clin Transl Neurol
. 2015 Aug;
2(7):756-68.
PMID: 26273688
Objective: Huntington's disease (HD) is a rare neurodegenerative disease caused by the expansion of an N-terminal repeat in the huntingtin protein. The protein is expressed in all cells in the...
3.
Rosas H, Doros G, Gevorkian S, Malarick K, Reuter M, Coutu J, et al.
Neurology
. 2014 Feb;
82(10):850-7.
PMID: 24510496
Objective: To assess the safety and tolerability of high-dose creatine, the feasibility of enrolling premanifest and 50% at-risk subjects in a prevention trial, and the potential of cognitive, imaging, and...
4.
Motsinger-Reif A, Zhu H, Kling M, Matson W, Sharma S, Fiehn O, et al.
Acta Neuropathol Commun
. 2013 Nov;
1:28.
PMID: 24252434
Background: A critical and as-yet unmet need in Alzheimer disease (AD) research is the development of novel markers that can identify individuals at risk for cognitive decline due to AD....
5.
Moscovitch-Lopatin M, Goodman R, Eberly S, Ritch J, Rosas H, Matson S, et al.
Neurology
. 2013 Aug;
81(13):1134-40.
PMID: 23966247
Objective: We measured the levels of mutant huntingtin (mtHtt) and total huntingtin (tHtt) in blood leukocytes from Prospective Huntington At-Risk Observational Study (PHAROS) subjects at 50% risk of carrying the...
6.
Zhu H, Bogdanov M, Boyle S, Matson W, Sharma S, Matson S, et al.
PLoS One
. 2013 Jul;
8(7):e68283.
PMID: 23874572
Therapeutic response to selective serotonin (5-HT) reuptake inhibitors in Major Depressive Disorder (MDD) varies considerably among patients, and the onset of antidepressant therapeutic action is delayed until after 2 to...
7.
Thomas B, Matson S, Chopra V, Sun L, Sharma S, Hersch S, et al.
Anal Biochem
. 2013 Feb;
436(2):112-20.
PMID: 23416183
Guanine methylation is a ubiquitous process affecting DNA and various RNA species. N-7 guanine methylation (7-MG), although relatively less studied, could have a significant role in normal transcriptional regulation as...
8.
Kaddurah-Daouk R, Yuan P, Boyle S, Matson W, Wang Z, Zeng Z, et al.
Sci Rep
. 2012 Sep;
2:667.
PMID: 22993692
Targeted metabolomics provides an approach to quantify metabolites involved in specific molecular pathways. We applied an electrochemistry-based, targeted metabolomics platform to define changes in tryptophan, tyrosine, purine and related pathways...
9.
Wright P, Wightman N, Huang M, Weiss A, Sapp P, Cuny G, et al.
Front Biosci (Elite Ed)
. 2012 Jun;
4(8):2701-8.
PMID: 22652679
Amyotrophic lateral sclerosis (ALS) is a fatal degenerative motor neuron disease. Approximately 20 percent of familial ALS cases are caused by mutations in the Cu/Zn superoxide dismutase (SOD1) gene. Rodents...
10.
Kaddurah-Daouk R, Rozen S, Matson W, Han X, Hulette C, Burke J, et al.
Alzheimers Dement
. 2010 Nov;
7(3):309-17.
PMID: 21075060
Background: Metabolomics, the global science of biochemistry, provides powerful tools to map perturbations in the metabolic network and enables simultaneous quantification of several metabolites to identify metabolic perturbances that might...